Ask the KD Experts: Why is Kawasaki disease less commonly treated with steroids? While it’s not common for Rady Children’s Hospital to treat Kawasaki disease (KD) with steroids, the use of steroids in combination with IVIG continues to be...
Read More
We are excited to announce the launch of our Lights On, Hearts Strong campaign this January, dedicated to raising awareness and funds for Kawasaki Disease! This campaign is an opportunity to illuminate the critical need for awareness about KD,...
**Your Input is Crucial! Help Shape a Toolkit for Pediatric Kawasaki Disease Patients Transitioning to Adult Cardiology Care** The KDF is reaching out to both youth and adult patients who are currently transitioning to adult healthcare or have successfully...
2024 Kawasaki Disease Parent Symposium Q&A Questions (Transcribed) Q: How can families participate in the KD genetic studies? Who qualifies to enroll and how? A: Currently, DNA studies are focused on patients with aneurysms. Families with a child who...
Dr. Tomisaku Kawasaki Memorial Scholarship – Call for Scholarship Applications Spring 2025 Deadline for Applications: February 28, 2025 The KD Foundation scholarship, established to honor Dr. Kawasaki’s contributions to pediatric medicine, will reopen on January 26, 2025, for the...
Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association Kawasaki disease (KD) is an acute febrile illness mainly affecting children under 5 and is the leading cause of acquired heart disease in...
Editorial: Fostering Global Collaboration Around Kawasaki Disease. Reflections From the 14th International Kawasaki Disease Symposium From August 26 to August 29, the 14th International Kawasaki Disease Symposium (IKDS) was held in Montreal, Canada. For the past 40 years, IKDS...
KDF Newsletter, Fall 2024 In this issue: 1. Treating Resistant KD: Evidence Update for Parents and Clinicians 2. Recap: 14th International KD Symposium (IKDS) 3. Watch the 2024 IKDS Parent Conference: Navigating KD Together 4. Watch On-Demand: 2024 Annual...
Comparing Two Treatments for IVIG-Resistant Kawasaki Disease – Evidence Update for Clinicians Children with resistant KD who received infliximab were more likely to have their fever resolve within 24 hours than were children who received a second dose of...
Comparing Two Treatments for Resistant Kawasaki Disease – Evidence Update for Parents Compared with children who received a second dose of IVIG, children who received infliximab were more likely to have their fever end within 24 hours. Children who...